Unknown PHASE3 INTERVENTIONAL NCT00396760

Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery

The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization

Sponsor: German Heart Center

Conditions Allogeneic Blood Transfusion Aortic Valve Replacement Bleeding and Cardiac Surgery Coronary Artery Bypass Graft Surgery

Interventions aprotinin or tranexamic acid

Updated 4 times since 2017 Last updated: Nov 6, 2006 Started: Jan 31, 2005 Completion: Jul 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Allogeneic Blood Transfusion and Aortic Valve Replacement, this trial is ongoing. The trial is conducted by German Heart Center and has accumulated 4 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE3

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Heart Center

Data source: German Heart Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany